<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.Org news tagged with: receptors</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Designing probiotics that ambush gut pathogens</title>
   	 <description>Researchers in Australia are developing diversionary tactics to fool disease-causing bacteria in the gut. Many bacteria, including those responsible for major gut infections, such as cholera, produce toxins that damage human tissues when they bind to complex sugar receptors displayed on the surface of cells in the host's intestine.</description>
     <link>http://phys.org/news171607326.html</link>
	 <category>Biology</category>
	 <pubDate>Tue, 08 Sep 2009 06:10:02 EST</pubDate>
	 <guid isPermaLink="false">news171607326</guid>
	 
</item>
<item>
     <title>Natural born killers -- how the body's frontline immune cells decide which cells to destroy</title>
   	 <description>(PhysOrg.com) -- The mechanism used by 'Natural Killer' immune cells in the human body to distinguish between diseased cells, which they are meant to destroy, and normal cells, which they are meant to leave alone, is revealed in new detail in research published today in PLoS Biology.</description>
     <link>http://phys.org/news167989314.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 28 Jul 2009 09:30:01 EST</pubDate>
	 <guid isPermaLink="false">news167989314</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/naturalbornk.jpg" width="90" height="135" />
</item>
<item>
     <title>Airway cells use 'tasting' mechanism to detect and clear harmful substances</title>
   	 <description>The same mechanism that helps you detect bad-tasting and potentially poisonous foods may also play a role in protecting your airway from harmful substances, according to a study by scientists at the University of Iowa Roy J. and Lucille A. Carver College of Medicine. The findings could help explain why injured lungs are susceptible to further damage.</description>
     <link>http://phys.org/news167664659.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 24 Jul 2009 15:20:02 EST</pubDate>
	 <guid isPermaLink="false">news167664659</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/airwaycellsu.jpg" width="90" height="94" />
</item>
<item>
     <title>Scientists discover key event in prostate cancer progression</title>
   	 <description>A study led by researchers at the Ohio State University Comprehensive Cancer Center and Dana-Farber Cancer Institute reveals how late-stage, hormone-independent prostate tumors gain the ability to grow without need of hormones.</description>
     <link>http://phys.org/news167571379.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 23 Jul 2009 12:50:02 EST</pubDate>
	 <guid isPermaLink="false">news167571379</guid>
	 
</item>
<item>
     <title>Eliminating cell receptor prevents infection in animal study</title>
   	 <description>New research from The Children's Hospital of Philadelphia sheds light on the role of cell receptors in acting as gatekeepers for infectious viruses. By using mice genetically engineered to lack a particular receptor in heart and pancreas cells, the study team prevented infection by a common virus that causes potentially serious diseases in humans.</description>
     <link>http://phys.org/news167489080.html</link>
	 <category>Biology</category>
	 <pubDate>Wed, 22 Jul 2009 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news167489080</guid>
	 
</item>
<item>
     <title>Barrow researchers identify new brain receptor, possible target for Alzheimer's treatment</title>
   	 <description>Barrow Neurological Institute researchers have identified a novel receptor in the brain that is extremely sensitive to beta-amyloid peptide (AB) and may play a key role in early stages of Alzheimer's disease.</description>
     <link>http://phys.org/news166975011.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 16 Jul 2009 14:57:12 EST</pubDate>
	 <guid isPermaLink="false">news166975011</guid>
	 
</item>
<item>
     <title>Toward an explanation for Crohn's disease?</title>
   	 <description>Twenty-five per cent of Crohn's disease patients have a mutation in what is called the NOD2 gene, but it is not precisely known how this mutation influences the disease. The latest study by Dr. Marcel Behr, of the Research Institute of the MUHC and McGill University, has provided new insight into how this might occur. The study will be published on July 9th in the Journal of Experimental Medicine. </description>
     <link>http://phys.org/news166354905.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 09 Jul 2009 10:42:15 EST</pubDate>
	 <guid isPermaLink="false">news166354905</guid>
	 
</item>
<item>
     <title>Researchers find new actions of neurochemicals (w/ Video)</title>
   	 <description>(PhysOrg.com) -- Although the tiny roundworm Caenorhabditis elegans has only 302 neurons in its entire nervous system, studies of this simple animal have significantly advanced our understanding of human brain function because it shares many genes and neurochemical signaling molecules with humans. Now MIT researchers have found novel C. elegans neurochemical receptors, the discovery of which could lead to new therapeutic targets for psychiatric disorders if similar receptors are found in humans.</description>
     <link>http://phys.org/news165763757.html</link>
	 <category>Chemistry</category>
	 <pubDate>Thu, 02 Jul 2009 14:29:41 EST</pubDate>
	 <guid isPermaLink="false">news165763757</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/20-researchersf.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists discover new information on spreading of cancer</title>
   	 <description>A joint research group of VTT Technical Research Centre of Finland and the University of Turku, led by Professor Johanna Ivaska, has discovered a mechanism lung cancer cells use when spreading into the body to form metastases.</description>
     <link>http://phys.org/news165569124.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 30 Jun 2009 09:00:04 EST</pubDate>
	 <guid isPermaLink="false">news165569124</guid>
	 
</item>
<item>
     <title>Flies avoid a plant's poison using a newly identified taste mechanism</title>
   	 <description>Many plants protect themselves from hungry animals by producing toxic chemicals. In turn, animals rely on detecting the presence of these harmful chemicals to avoid consuming dangerous plant material. A paper, published in this week's issue of PLoS Biology, investigates the response of an insect to a common plant weapon - the toxin L-canavanine.</description>
     <link>http://phys.org/news165566601.html</link>
	 <category>Biology</category>
	 <pubDate>Tue, 30 Jun 2009 08:20:01 EST</pubDate>
	 <guid isPermaLink="false">news165566601</guid>
	 
</item>
<item>
     <title>Trial shows promise for arthritis drug</title>
   	 <description>A clinical trial of masitinib, a drug in development for the treatment of rheumatoid arthritis, has shown it to be well tolerated and effective. Researchers writing in BioMed Central's open access journal Arthritis Research and Therapy have shown that treatment with masitinib significantly reduced the severity of active arthritis.</description>
     <link>http://phys.org/news165296111.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sat, 27 Jun 2009 04:36:39 EST</pubDate>
	 <guid isPermaLink="false">news165296111</guid>
	 
</item>
<item>
     <title>Vitamin A derivative provides clues to better breast cancer drugs</title>
   	 <description>Retinoic acid, a derivative of vitamin A, could lead researchers to a new set of drug targets for treating breast cancer, researchers from the University of Chicago report in the June 25, 2009, issue of the journal Cell.</description>
     <link>http://phys.org/news165152817.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 25 Jun 2009 13:00:01 EST</pubDate>
	 <guid isPermaLink="false">news165152817</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/vitaminaderi.jpg" width="90" height="116" />
</item>
<item>
     <title>Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells</title>
   	 <description>Pancreatic cancer is a devastating disease with poor prognosis. This warrants the development of novel therapies including gene therapy. However, clinical studies have demonstrated poor efficacy of adenoviral gene therapy because of the absence of adenoviral binding sites on pancreatic cancer cells such as the coxsackie and adenovirus receptor (CAR). Circumventing CAR-mediated entry therefore seems a promising option to improve adenoviral entry into pancreatic cancer cells and to enhance the efficacy of adenoviral vectors.</description>
     <link>http://phys.org/news164977499.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 23 Jun 2009 12:06:32 EST</pubDate>
	 <guid isPermaLink="false">news164977499</guid>
	 
</item>
<item>
     <title>Targeting helpers of heat shock proteins could help treat cancer, cardiovascular disease</title>
   	 <description>Dissecting how heat shock protein 90 gets steroid receptors into shape to use hormones like estrogen and testosterone could lead to targeted therapies for hormone-driven cancers, such as breast and prostate, that need them as well, Medical College of Georgia researchers say.</description>
     <link>http://phys.org/news164891162.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 22 Jun 2009 12:07:48 EST</pubDate>
	 <guid isPermaLink="false">news164891162</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/targetinghel.jpg" width="90" height="84" />
</item>
<item>
     <title>Researchers Find Shared Motif in Membrane Transport Proteins Found in Plants, Bacteria</title>
   	 <description>(PhysOrg.com) -- University of Arkansas researchers have characterized a membrane receptor protein and its binding mechanism from chloroplasts in plants and determined that it shares a commonly shaped binding site and mechanism with a similar protein found in E. coli.</description>
     <link>http://phys.org/news163172312.html</link>
	 <category>Chemistry</category>
	 <pubDate>Tue, 02 Jun 2009 14:39:32 EST</pubDate>
	 <guid isPermaLink="false">news163172312</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/19-researchersf.jpg" width="90" height="135" />
</item>
<item>
     <title>How to get obese mice moving -- and cure their diabetes</title>
   	 <description>Mice lacking the fat hormone leptin or the ability to respond to it become morbidly obese and severely diabetic—not to mention downright sluggish. Now, a new study in the June Cell Metabolism shows that blood sugar control in those animals can be completely restored by returning leptin sensitivity to a single class of neurons in the brain, which account for only a small fraction of those that normally carry the hormone receptors.</description>
     <link>http://phys.org/news163164889.html</link>
	 <category>Biology</category>
	 <pubDate>Tue, 02 Jun 2009 12:36:37 EST</pubDate>
	 <guid isPermaLink="false">news163164889</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/howtogetobes.jpg" width="90" height="113" />
</item>
<item>
     <title>Protein that suppresses androgen receptors could improve prostate cancer diagnosis, treatment</title>
   	 <description>A protein that helps regulate expression of androgen receptors could prove a new focal point for staging and treating testosterone-fueled prostate cancer, Medical College of Georgia researchers say.</description>
     <link>http://phys.org/news162043713.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 20 May 2009 13:09:01 EST</pubDate>
	 <guid isPermaLink="false">news162043713</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/proteinthats.jpg" width="90" height="84" />
</item>
<item>
     <title>Sniffing Out the Physical Condition of Conspecifics </title>
   	 <description>To date, it has been unknown exactly how mammals are capable of sniffing out whether a conspecific is ill. The biologists Prof. Marc Spehr and Daniela Flügge are following a good lead. They have discovered that a messenger substance of the immune system that attracts defence cells to the affected site in bacterial infections also responds to receptors in the vomeronasal organ (VMO, Jacobson's organ). This organ, which has hardly been studied to date, reacts to pheromones and is also held responsible for spontaneous aversion or attraction when selecting a partner. The results of this study on the newly detected receptor family FPR (formyl peptide receptor) within the olfactory system have been published in the current Internet edition of Nature.</description>
     <link>http://phys.org/news160905741.html</link>
	 <category>Biology</category>
	 <pubDate>Thu, 07 May 2009 09:02:48 EST</pubDate>
	 <guid isPermaLink="false">news160905741</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/Spehr_Fluegge.jpg" width="90" height="65" />
</item>
<item>
     <title>Understanding a target of quinoline drugs</title>
   	 <description>The full details about the molecules and mechanisms that underlie the development of autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus, remain to be discovered. One compound that may have a role in alleviating these conditions is quinoline-3-carboxamide, which is currently being tested in various clinical trials. In this week's PLoS Biology, researchers from Lund University, Sweden, the University of Munster in Germany, and the company Active Biotech AB, identify a molecular target for quinoline compounds.</description>
     <link>http://phys.org/news160129369.html</link>
	 <category>Biology</category>
	 <pubDate>Tue, 28 Apr 2009 09:23:20 EST</pubDate>
	 <guid isPermaLink="false">news160129369</guid>
	 
</item>
<item>
     <title>Dietary fats trigger long-term memory formation</title>
   	 <description>Having strong memories of that rich, delicious dessert you ate last night? If so, you shouldn't feel like a glutton. It's only natural.</description>
     <link>http://phys.org/news160072047.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 27 Apr 2009 17:28:09 EST</pubDate>
	 <guid isPermaLink="false">news160072047</guid>
	 
</item>
<item>
     <title>A new twist in the sex life of silk worms</title>
   	 <description>(PhysOrg.com) -- A quirk in the sex life of the silkworm (Bombyx mori) has been revealed by a team of CSIRO Food Futures Flagship scientists led by Dr Alisha Anderson.</description>
     <link>http://phys.org/news159717639.html</link>
	 <category>Biology</category>
	 <pubDate>Thu, 23 Apr 2009 15:03:07 EST</pubDate>
	 <guid isPermaLink="false">news159717639</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/anadultsilkw.jpg" width="90" height="59" />
</item>
<item>
     <title>Our brains make their own marijuana: We're all pot heads deep inside</title>
   	 <description>U.S. and Brazilian scientists have just proven that one of Bob Dylan's most famous lines—&quot;everybody must get stoned&quot;— is correct. That's because they've discovered that the brain manufactures proteins that act like marijuana at specific receptors in the brain itself. This discovery, published online in The FASEB Journal, may lead to new marijuana-like drugs for managing pain, stimulating appetite, and preventing marijuana abuse.</description>
     <link>http://phys.org/news159465099.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Apr 2009 16:51:59 EST</pubDate>
	 <guid isPermaLink="false">news159465099</guid>
	 
</item>
<item>
     <title>Colon cancer shuts down receptor that could shut it down</title>
   	 <description>Though a high-fiber diet has long been considered good for you and beneficial in staving off colon cancer, Medical College of Georgia researchers have discovered a reason why: roughage activates a receptor with cancer-killing potential.</description>
     <link>http://phys.org/news158849074.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 13 Apr 2009 13:45:18 EST</pubDate>
	 <guid isPermaLink="false">news158849074</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/coloncancers.jpg" width="90" height="84" />
</item>
<item>
     <title>Prune juice not necessary: New research should make bowel movements easier</title>
   	 <description>If you hate prune juice and chalky fiber supplements, just sit down and relax. Help is on the way. In a research report published online in The FASEB Journal, a team of researchers has discovered a new way to make it a lot easier to go to the bathroom, especially when all other methods fail. Specifically, they have found a group of nerve ending receptors which, when stimulated, causes the bowels to pass waste, and the specific receptor needed to activate bowel clearance. Furthermore, they tested chemicals that work with those receptors, providing a blueprint for the development of new laxatives.</description>
     <link>http://phys.org/news158420857.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 08 Apr 2009 14:48:11 EST</pubDate>
	 <guid isPermaLink="false">news158420857</guid>
	 
</item>
<item>
     <title>Biology of flushing could renew niacin as cholesterol drug</title>
   	 <description>Deft molecular detective work at Duke University Medical Center suggests that scientists may soon be able to resurrect niacin as one of the best and cheapest ways to manage cholesterol.</description>
     <link>http://phys.org/news158258162.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 06 Apr 2009 17:39:12 EST</pubDate>
	 <guid isPermaLink="false">news158258162</guid>
	 
</item>
<item>
     <title>Biomarker associated with poor outcome in aggressive childhood cancer</title>
   	 <description>Results from a new study identify a biomarker that may be useful for predicting the outcome of treatment for neuroblastoma, the most common cancer in young children. The research, published by Cell Press in the April 7th issue of the journal Cancer Cell, also provides new information about the molecular signals that are involved in the progression of this often devastating pediatric cancer.</description>
     <link>http://phys.org/news158245194.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 06 Apr 2009 14:00:25 EST</pubDate>
	 <guid isPermaLink="false">news158245194</guid>
	 
</item>
<item>
     <title>Glaxo seeks OK to expand breast cancer drug use</title>
   	 <description>(AP) --  GlaxoSmithKline PLC on Wednesday applied for approval in the U.S. and Europe to sell an existing breast-cancer drug as a first-line treatment.</description>
     <link>http://phys.org/news157815399.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Apr 2009 14:37:00 EST</pubDate>
	 <guid isPermaLink="false">news157815399</guid>
	 
</item>
<item>
     <title>Protein from tick saliva studied for potential myasthenia gravis treatment</title>
   	 <description>Looking for a better treatment for the autoimmune disease myasthenia gravis, researchers have found that a protein in tick saliva shows promise in limiting the severity of the disease in an animal model in a study published in the Annals of Neurology.</description>
     <link>http://phys.org/news157283436.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 26 Mar 2009 10:51:05 EST</pubDate>
	 <guid isPermaLink="false">news157283436</guid>
	 
</item>
<item>
     <title>Researchers find tiny genetic change keeps nicotine from binding to muscle cells</title>
   	 <description>A tiny genetic mutation is the key to understanding why nicotine--which binds to brain receptors with such addictive potency--is virtually powerless in muscle cells that are studded with the same type of receptor. That's according to California Institute of Technology (Caltech) researchers, who report their findings in the March 26 issue of the journal Nature.</description>
     <link>http://phys.org/news157043211.html</link>
	 <category>Chemistry</category>
	 <pubDate>Mon, 23 Mar 2009 16:07:28 EST</pubDate>
	 <guid isPermaLink="false">news157043211</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/caltechresea.jpg" width="90" height="92" />
</item>
<item>
     <title>Taking the conversation inside: Enhancing signals in cell interior</title>
   	 <description>Scientists used to think most of the exchange of information between cells was conducted at the surface, where cell receptors receive signals from other cells.</description>
     <link>http://phys.org/news156711582.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 19 Mar 2009 20:00:38 EST</pubDate>
	 <guid isPermaLink="false">news156711582</guid>
	 
</item>


</channel>
</rss>
